Record Display for the EPA National Library Catalog

RECORD NUMBER: 10 OF 20

Main Title Effect of Repeated Organophosphate Administration on Carbachol-Stimulated Phosphoinositide Hydrolysis in the Rat Brain.
Author Mundy, W. R. ; Ward, T. R. ; Dulchinos, V. F. ; Tilson, H. A. ;
CORP Author Health Effects Research Lab., Research Triangle Park, NC. Neurotoxicology Div.
Publisher c1993
Year Published 1993
Report Number EPA/600/J-93/374;
Stock Number PB93-229003
Additional Subjects Organophosphorus compounds ; Carbachol ; Phosphoinositides ; Isoflurophate ; Hydrolysis ; Inositol phosphates ; Muscarinic receptors ; Hippocampus ; Second messenger system ; Disulfoton ; Myoinositol ; Lithium ; Dose-response relationships ; Reprints ;
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB93-229003 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 8p
Abstract
The effects of repeated exposure to two organophosphates on the turnover of phosphoinositides, the second messenger system coupled to the M1 and M3 subtypes of muscarinic receptors, were examined in the rat hippocampus. Repeated diisopropylfluorophosphate (DFP) exposure (0.2-0.8 mg/kg, SC) decreased brain acetylcholinesterase activity and muscarinic receptor density. The incorporation of (3H)myoinositol into brain slices was also decreased. Phosphoinositide turnover was measured as the accumulation of (3H)inositol phosphates (IP) in the presence of lithium. DFP did not affect basal IP accumulation, but decreased carbachol-stimulated IP accumulation in the hippocampus after 0.4 and 0.8 mg/kg. The effects of repeated disulfoton administration (2.0 mg/kg, IP) were also examined in the hippocampus. Similar to DFP, repeated disulfoton exposure decreased acetylcholinesterase activity, receptor density, and carbachol-stimulated IP accumulation. The incorporation of myoinositol, however, was increased in disulfoton-treated rats. These data indicate that repeated organophosphate exposure results in a functional decrease in muscarinic receptor activity, as well as changes in myoinositol incorporation into phospholipids.